merbromin has been researched along with Coronary Disease in 1 studies
Merbromin: A once-popular mercury containing topical antiseptic.
merbromin : An organic sodium salt that is 2,7-dibromo-4-hydroxymercurifluorescein in which the carboxy group and the phenolic hydroxy group have been deprotonated and the resulting charge is neutralised by two sodium ions.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postoperative treatment of ventricular arrhythmia with MSC is a promising procedure and merits further clinical and experimental investigation." | 1.26 | Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease. ( Janota, M; Málek, P; Vrána, M; Vránová, Z, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vránová, Z | 1 |
| Janota, M | 1 |
| Málek, P | 1 |
| Vrána, M | 1 |
1 other study available for merbromin and Coronary Disease
| Article | Year |
|---|---|
Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; Drug Evaluat | 1976 |